RAGE deficiency ameliorates autoimmune hepatitis involving inhibition of IL-6 production via suppressing protein Arid5a in mice.

[1]  Xiaohui Wang,et al.  Inhibition of HMGB1 involved in the protective of salidroside on liver injury in diabetes mice. , 2020, International immunopharmacology.

[2]  R. Wu,et al.  Assessment of EN-RAGE, sRAGE and EN-RAGE/sRAGE as potential biomarkers in patients with autoimmune hepatitis , 2020, Journal of translational medicine.

[3]  Rashmi Ray,et al.  RAGE and its ligands: from pathogenesis to therapeutics , 2020, Critical reviews in biochemistry and molecular biology.

[4]  Y. Nie,et al.  Interplay between RAGE and TLR4 Regulates HMGB1-Induced Inflammation by Promoting Cell Surface Expression of RAGE and TLR4 , 2020, The Journal of Immunology.

[5]  D. Foell,et al.  The Receptor for Advanced Glycation Endproducts (RAGE) Contributes to Severe Inflammatory Liver Injury in Mice , 2020, Frontiers in Immunology.

[6]  T. Kishimoto,et al.  Arid5a Regulation and the Roles of Arid5a in the Inflammatory Response and Disease , 2019, Front. Immunol..

[7]  Xiao-Ming Yin,et al.  Role of High-Mobility Group Box-1 in Liver Pathogenesis , 2019, International journal of molecular sciences.

[8]  F. Gong,et al.  Glycyrrhizin attenuates hepatic ischemia‐reperfusion injury by suppressing HMGB1‐dependent GSDMD‐mediated kupffer cells pyroptosis , 2019, International immunopharmacology.

[9]  N. Nieto,et al.  High Mobility Group Box‐1 Drives Fibrosis Progression Signaling via the Receptor for Advanced Glycation End Products in Mice , 2018, Hepatology.

[10]  D. Standley,et al.  TLR4-induced NF-κB and MAPK signaling regulate the IL-6 mRNA stabilizing protein Arid5a , 2017, Nucleic acids research.

[11]  Standley,et al.  Arid5a regulates naive CD4+ T cell fate through selective stabilization of Stat3 mRNA , 2016, The Journal of experimental medicine.

[12]  M. Cho,et al.  HMGB1/RAGE induces IL-17 expression to exaggerate inflammation in peripheral blood cells of hepatitis B patients , 2015, Journal of Translational Medicine.

[13]  L. Yatime,et al.  The specificity of DNA recognition by the RAGE receptor , 2014, The Journal of experimental medicine.

[14]  Jianling Xie,et al.  Cellular signalling of the receptor for advanced glycation end products (RAGE). , 2013, Cellular signalling.

[15]  R. Sinha,et al.  Soluble receptor for advanced glycation end products and risk of liver cancer , 2013, Hepatology.

[16]  H. Kiyonari,et al.  Arid5a controls IL-6 mRNA stability, which contributes to elevation of IL-6 level in vivo , 2013, Proceedings of the National Academy of Sciences.

[17]  Hongwei H Zhang,et al.  Blockade of IL-33 ameliorates Con A-induced hepatic injury by reducing NKT cell activation and IFN-γ production in mice , 2012, Journal of Molecular Medicine.

[18]  K. Tracey,et al.  HMGB1 is a therapeutic target for sterile inflammation and infection. , 2011, Annual review of immunology.

[19]  F. Tacke,et al.  Role of IL-17 and Th17 Cells in Liver Diseases , 2010, Clinical & developmental immunology.

[20]  P. Xiong,et al.  High-mobility group box 1 exacerbates concanavalin A-induced hepatic injury in mice , 2010, Journal of Molecular Medicine.

[21]  A. Coyle,et al.  HMGB1 and RAGE in inflammation and cancer. , 2010, Annual review of immunology.

[22]  Jun Hee Lee,et al.  Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression , 2010, Cell.

[23]  J. Emond,et al.  Blockade of receptor for advanced glycation end product (RAGE) attenuates ischemia and reperfusion injury to the liver in mice , 2004, Hepatology.

[24]  Zhi Chen,et al.  Hepatitis B virus X protein stimulates IL-6 expression in hepatocytes via a MyD88-dependent pathway. , 2011, Journal of hepatology.